An AusDoc survey has highlighted an opportunity for the pharmaceutical industry to help speed up the pathway to diagnosis and treatment of patients with rare diseases.
Can pharmaceutical companies plug the gap in rare disease confidence?
While eight in every hundred Australians has a rare disease, GPs lack confidence in identifying these patients, which may delay diagnosis and treatment.
Older weight-loss brands still popular among prescribers
Most respondents to an AusDoc survey prescribe weight-loss medications at least once a month, with legacy products enjoying strong brand recall alongside the newer entrants to the market.
Australian doctors report a surge in patient questions about weight-loss meds, but survey finds a lack of confidence to answer
More than 85% of doctors report an increased number of patients asking about weight-loss medication over the past 12 months, but many lack confidence to discuss newer treatments, according to an exclusive AusDoc survey.
Greater than the sum of its parts – Omnichannel insights from two industry experts
Even though Pfizer’s customers prefer face-to-face, most of their engagement is digital, writes Clifford Fram, director of partnerships and innovation at adg. Claire Edgerton’s morning fix is to check the data. She likes to know what content and channels Pfizer’s customers are engaging with – what they’re reading, what they’re watching and what they’re searching
8 Tips for Engaging Busy Doctors with your Digital Content
The digital revolution has had a significant positive impact on how doctors’ access pharmaceutical information, especially in the post-COVID-19 era. This has ultimately enhanced the quality use of medicines and patient care. More recently, with the ubiquitous use of the word ’omnichannel’, the short-term challenge for pharma is finding the right mix between traditional face-to-face
AusDoc survey uncovers top 5 pathology-led GP education opportunities
A recent AusDoc survey of 418 GPs and GP registrars focusing on pathology tests has uncovered a raft of unmet needs for GP education, and opened up a range of opportunities for pathology organisations and pharma companies to offer meaningful med ed. Respondents were crying out for further education, with several key areas of particular
AusDoc survey puts GPs’ pathology testing views under the microscope
Pathology testing and the interpretation of results are regular challenges for many GPs, and there are several key areas that are particularly problematic, an AusDoc survey of 418 GPs and GP registrars has revealed. 1. Ordering tests: vague symptoms pose problems When it comes to deciding which pathology tests to order, the clinical presentations that
5 ways to choose the right content type for your campaign
Have you ever wondered which type of content will work best for your campaign? If so, you’re not alone. It’s one of the most frequently asked questions AusDoc receives from marketers and agencies. The key to success is to think like a journalist, says Amanda Davey, AusDoc Commercial Content Editor and the former editor of
Exclusive AusDoc survey: Understanding doctors’ perceptions and behaviours regarding medicinal cannabis
Exclusive AusDoc survey. What you will learn from reading this article: Doctors are experiencing increased patient demand for medicinal cannabis, but most acknowledge a lack of knowledge about risks and benefits and are unsure how to advise patients, says a 2021 meta-analysis of 21 international articles. Fast-forward to 2023 and not much has changed, according
How a lack of brand awareness is creating an opportunity for medicinal cannabis marketers
Exclusive AusDoc survey. What you will learn from reading this article: Doctors have little knowledge of medicinal cannabis brands, according to the results of an AusDoc survey involving more than 240 GPs and specialists across Australia. In a finding that leaves space wide open for marketers to build their brand equity, 77% of survey respondents
Is your Medical Affairs engagement strategy ready for an omnichannel future?
Medical Affairs professionals must demonstrate digital competency and mindset change to continue benefiting from the Covid-19 digital transformation, according to an opinion article by Daniel Furtner and colleagues. They write that engagement of the future will need to be high quality and tailored to individual doctors’ needs and preferences. And digital tools will replace many